Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-Centered Prescription Opioid Tapering Methods : A Randomized Clinical Trial.

Annals of internal medicine·2026
Same author

What nourishes us: psychometric validation of culturally grounded measures of indigenous nourishment in a cross-sectional study of two urban native communities.

Public health nutrition·2026
Same author

Are self-management skills associated with depressive symptoms, quality of life, and healthcare utilisation? A cross-sectional survey among patients with advanced cancer in the Netherlands.

BMJ open·2026
Same author

Association of Veggie Meter-Assessed Skin Carotenoids and Dietary Intake Among Indigenous Families: The Indigenous Supported Agriculture "Go Healthy" Study.

Current developments in nutrition·2025
Same author

Editorial Statement in Response to US Policies on Scientific Research and Publishing.

Progress in community health partnerships : research, education, and action·2025
Same author

Exploring Definitions, Correlates, and Solutions to Food Insecurity during COVID-19: A Mixed Methods CBPR Study with the Baltimore Native Community.

American Indian and Alaska native mental health research (Online)·2025
Same journal

30-Year Trends in Microvascular Complications and Treatment in Adolescents With Type 1 Diabetes.

Diabetes care·2026
Same journal

Reactive Hypoglycemia as a Transient Metabolic Phenotype of Stage 1 and 2 Type 1 Diabetes.

Diabetes care·2026
Same journal

Type 1 Diabetes Driven by Residual Recipient T Cells After Hematopoietic Cell Transplantation: A Case Report.

Diabetes care·2026
Same journal

Predicting the Path to Attrition: Multidomain Risk Assessment in Diabetic Foot Ulcer Offloading Randomized Controlled Trials.

Diabetes care·2026
Same journal

Habituation to Elevated Glucose Levels in Type 1 Diabetes: Function and Well-Being in Guideline-Based Versus Typical Glycemic Range.

Diabetes care·2026
Same journal

The Correlation Between Fear and Perceived Frequency of Hypoglycemia and Continuous Glucose Monitoring Metrics in Adults With Type 1 Diabetes Using Diabetes Technology: A One-Year Analysis.

Diabetes care·2026
See all related articles

Related Experiment Videos

Online diabetes self-management program: a randomized study.

Kate Lorig1, Philip L Ritter, Diana D Laurent

  • 1Stanford Patient Education Research Center, Stanford University School of Medicine, Palo Alto, California, USA.

Diabetes Care
|March 20, 2010
PubMed
Summary
This summary is machine-generated.

An online diabetes self-management program improved A1C, self-efficacy, and patient activation in adults with type 2 diabetes. The program also benefited American Indian/Alaska Native participants, though reinforcement strategies did not enhance outcomes.

Related Experiment Videos

Area of Science:

  • Digital health interventions
  • Diabetes self-management
  • Health behavior change

Background:

  • Type 2 diabetes management requires effective self-management strategies.
  • Online programs offer scalable solutions for diabetes care.
  • Assessing the impact of digital interventions on clinical outcomes and patient engagement is crucial.

Purpose of the Study:

  • To evaluate an online diabetes self-management program's effectiveness compared to usual care.
  • To assess the impact of reinforcement strategies on program outcomes.
  • To examine program efficacy in diverse populations, including American Indians/Alaska Natives.

Main Methods:

  • Randomized controlled trial with 761 participants with type 2 diabetes.
  • Three arms: online program, online program with e-mail reinforcement, and usual care control.
  • Analyses of covariance used for 6- and 18-month follow-up comparisons.

Main Results:

  • Program participants showed improved A1C, patient activation, and self-efficacy at 6 months.
  • American Indian/Alaska Native participants experienced reduced health distress and activity limitation.
  • No significant benefits observed from reinforcement strategies; A1C was not measured at 18 months.

Conclusions:

  • The online diabetes self-management program is a viable option for individuals with type 2 diabetes.
  • The program demonstrates potential benefits for A1C reduction and patient engagement, particularly in American Indian/Alaska Native populations.
  • E-mail reinforcement did not yield additional improvements in outcomes.